Telomir Pharmaceuticals, Inc.
TELO
$1.26
-$0.03-2.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 475.52% | 778.18% | -59.96% | -87.69% | 105,408.33% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -5.53% | -5.82% | -14.24% | -10.73% | 8,171.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 454.49% | 610.37% | -60.53% | -85.98% | 204.23% |
|
|
|||||
| Total Current Assets | 454.49% | 610.37% | -60.53% | -85.98% | 204.23% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 454.49% | 610.37% | -60.53% | -85.98% | -72.27% |
|
|
|||||
| Total Accounts Payable | -8.63% | -34.97% | -35.25% | 152.21% | -16.93% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 407.28% | 0.00% | -33.43% | 1,082.28% | -85.14% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 109.69% | -29.52% | -34.78% | 34.05% | -49.01% |
|
|
|||||
| Total Current Liabilities | 109.69% | -29.52% | -34.78% | 34.05% | -49.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 407.28% | 0.00% | -33.43% | 1,082.28% | -85.14% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 109.69% | -29.52% | -34.78% | 34.05% | -49.01% |
|
|
|||||
| Common Stock & APIC | 50.20% | 63.21% | 64.25% | 39.77% | 78.49% |
| Retained Earnings | -34.03% | -40.62% | -73.87% | -61.31% | -117.55% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 819.66% | 1,478.67% | -69.30% | -105.34% | -81.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 819.66% | 1,478.67% | -69.30% | -105.34% | -81.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 819.66% | 1,478.67% | -69.30% | -105.34% | -81.30% |
|
|
|||||